Valneva SE (VALN) Other Non-Current Liabilities (2020 - 2026)

Valneva SE's (VALN) quarterly Other Non-Current Liabilities came in at $14.4 million in Q1 2026, up 140.16% year-on-year from $6.0 million in Q1 2025, and up 6.4% quarter-over-quarter from $13.6 million in Q4 2025.

Valneva SE (VALN) Other Non-Current Liabilities (2020 - 2026) Analysis & Trends

Valneva SE has disclosed Other Non-Current Liabilities across 7 years of filings, most recently posting $14.4 million for Q1 2026.

  • Other Non-Current Liabilities for Q1 2026 came in at $14.4 million, up 140.16% year-over-year; the trailing twelve-month figure through Mar 2026 was $14.4 million (up 140.16% YoY), and the FY2025 annual result was $13.6 million, up 2226.08% from the prior year.
  • Other Non-Current Liabilities came in at $14.4 million for Q1 2026 at Valneva SE, up from $13.6 million in the prior quarter.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $60.7 million in Q2 2022 to a low of $583453.1 in Q4 2024.
  • The 5-year median for Other Non-Current Liabilities is $10.4 million (2024), against an average of $15.0 million.
  • Across the five-year window, Other Non-Current Liabilities plunged 77.31% in 2023 and jumped 2226.08% in 2025, its largest moves.
  • Valneva SE's Other Non-Current Liabilities stood at $1.3 million in 2022, then decreased by 14.19% to $1.2 million in 2023, then plunged by 49.51% to $583453.1 in 2024, then soared by 2226.08% to $13.6 million in 2025, then grew by 6.4% to $14.4 million in 2026.
  • The last three Other Non-Current Liabilities figures came in at $14.4 million (Q1 2026), $13.6 million (Q4 2025), and $12.4 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 723,416.35 Bn 723,416.32 Bn -
2 Belite Bio 57,340.00 Bn 57,340.00 Bn -
3 Quantum Biopharma 19,125.08 Bn 19,125.08 Bn -
4 Legend Biotech 3,262.00 Bn 3,261.71 Bn 242.10 Mn
5 Akari Therapeutics 1,789.67 Bn 1,789.67 Bn -
6 Evaxion A 1,480.39 Bn 1,480.37 Bn -
7 Psyence Biomedical 241.78 Bn 241.78 Bn -
8 Vertex Pharmaceuticals 113.54 Bn 106.29 Bn 2.59 Bn
9 Abivax 94.26 Bn 94.26 Bn -
10 Valneva SE 167.33 Mn 44.10 Mn 5.08 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 14.44 Mn
Dec 31, 2025 13.57 Mn
Sep 30, 2025 12.36 Mn
Jun 30, 2025 6.62 Mn
Mar 31, 2025 6.01 Mn
Dec 31, 2024 583,453.09
Sep 30, 2024 8.01 Mn
Jun 30, 2024 7.50 Mn
Mar 31, 2024 10.38 Mn
Dec 31, 2023 1.16 Mn
Sep 30, 2023 10.35 Mn
Jun 30, 2023 13.77 Mn
Mar 31, 2023 25.80 Mn
Dec 31, 2022 1.35 Mn
Sep 30, 2022 27.92 Mn
Jun 30, 2022 60.70 Mn
Mar 31, 2022 34.29 Mn
Dec 31, 2021 78,934.00
Dec 31, 2020 85,844.87